The role of probiotic bacteria in cancer prevention

Microbes and Infection

Volumn 2, Issue 6, 2000, Pages 681-686

  Hirayama, Kazuhiro ^a   Rafter, Joseph ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anticarcinogens; Colon cancer; Intestinal microflora; Lactic acid bacteria; Probiotic bacteria

Indexed keywords

CANCER MORTALITY; CANCER PREVENTION; COLORECTAL CANCER; HUMAN; INTESTINE FLORA; LACTIC ACID BACTERIUM; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

BACTERIA (MICROORGANISMS);

EID: 0034096251     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00357-9     Document Type: Review

References (63)

1. Parker S.L., Tong T., Bolden S., Wong P.A. Cancer Statistics, 1996. CA-A Cancer J. Clin. 397:1996;5-27.
2. Lankaputhra W.E.V., Shah N.P. Antimutagenic properties of probiotic bacteria and of organic acids. Mutat. Res. 20:1998;169-182.
3. Pool-Zobel B.L., Munzner R., Holzapfel W.H. Antigenotoxic properties of lactic acid bacteria in the S. typhimurium mutagenicity assay. Nutr. Cancer. 74:1993;261-270.
4. Zhang X.B., Ohta Y. In vitro binding of mutagenic pyrolyzates to lactic acid bacterial cells in human gastric juice. J. Dairy Sci. 311:1991;752-757.
5. Orrhage K., Sillerstrom E., Gustafsson J.A., Nord C.E., Rafter J. Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat. Res. 74:1994;239-248.
6. Zhang X.B., Ohta Y. Binding of mutagens by fractions of the cell wall skeleton of lactic acid bacteria. J. Dairy Sci. 46:1991;1477-1481.
7. Reddy G.V., Friend B.A., Shahani K.M., Farmer R.E. Antitumor activity of yogurt components. J. Food Protect. 50:1983;8-11.
8. Reddy G.V., Shahani K.M., Benerjee M.R. Inhibitory effect of yogurt on Ehrlich ascites tumor cell proliferation. J. Natl. Cancer Inst. 16:1973;815-817.
9. Baricault L., Denariaz G., Houri J.J., Bouley C., Sapin C., Trugnan G. Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis. 26:1995;245-252.
10. Pool-Zobel B.L., Neudecker C., Domizlaff I., Ji S., Schillinger U., Rumney C., Moretti M., Vilarini I., Scassellati-Sforzolini R., Rowland I. Lactobacillus- and Bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr. Cancer. 25:1996;365-380.
11. Goldin B.R., Gualtieri L.J., Moore R.P. The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat. Nutr. Cancer. 238:1996;197-204.
12. Arimochi H., Kinouchi T., Kataoka K., Kuwahara T., Ohnishi Y. Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon. Biochem. Biophys. Res. Commun. 18:1997;753-757.
13. Challa A., Rao D.R., Chawan C.B., Shackelford L. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis. 207:1997;517-521.
14. Kulkarni N., Reddy B.S. Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial β-glucuronidase. Proc. Soc. Exp. Biol. M. 126:1994;278-283.
15. Gallaher D.D., Stallings W.H., Blessing L.L., Busta F.F., Brady L.J. Probiotics, cecal microflora, and aberrant crypts in the rat colon. J. Nutr. 24:1996;1362-1371.
16. Abdelali H., Cassand P., Soussotte V., Daubeze M., Bouley C., Narbonne J.F. Effect of dairy products on initiation of precursor lesions of colon cancer in rats. Nutr. Cancer. 19:1995;121-132.
17. Rowland I.R., Rumney C.J., Coutts J.T., Lievense L.C. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis. 113:1998;281-285.
18. Onoue M., Kado S., Sakaitani Y., Uchida K., Morotomi M. Specific species of intestinal bacteria influence the induction of aberrant crypt foci by 1, 2-dimethylhydrazine in rats. Cancer Lett. 53:1997;179-186.
19. Reddy B.S., Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4, 5-f]quinoline, a food mutagen. Cancer Res. 69:1993;3914-3918.
20. Kohwi T., Imai K., Tamura A., Hashimoto Y. Antitumor effect of Bifidobacterium infantis in mice. Gann. 64:1978;613-618.
21. Goldin B.R., Gorbach S.L. Effect of Lactobacillus acidophilus dietary supplements on 1, 2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J. Natl. Cancer Inst. 5:1980;263-265.
22. Shackelford L.A., Rao D.R., Chawan C.B., Pulusani S.R. Effect of feeding fermented milk on the incidence of chemically-induced colon tumors in rats. Nutr. Cancer. 18:1983;159-164.
23. Singh J., Rivenson A., Tomita M., Shimamura S., Ishibashi N., Reddy B.S. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis. 37:1997;833-841.
24. Friend B.A., Farmer R.E., Shahani K.M. Effect of feeding and intraperitoneal implantation of yogurt culture cells on Ehrlich ascites tumor. Milch Wissenschaft. 72:1982;708-710.
25. Kato I., Kobayashi S., Yokokura T., Mutai M. Antitumor activity of Lactobacillus casei in mice. Gann. 45:1981;517-523.
26. Sekine K., Toida T., Saito M., Kuboyama M., Kawashima T., Hashimoto Y. A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. Cancer Res. 33:1985;1300-1307.
27. Shahani K.M., Ayebo A.D. Role of dietary lactobacilli in gastrointestinal microecology. Am. J. Clin. Nutr. 3:1980;2448-2457.
28. Malhotra S.L. Dietary factors in a study of colon cancer from cancer registry, with special reference to the role of saliva, milk, and fermented milk products and vegetable fibre. Med. Hypotheses. 2:1977;122-134.
29. transit time, fecal bacteria, steroids, and colon cancer in two Scandinavian Populations. Lancet. 3:1977;207-211.
30. Peters R.K., Pike M.C., Garabrant D., Mack T.M. Diet and colon cancer in Los Angeles County, California. Cancer Causes Control. 42:1992;457-473.
31. Young T.B., Wolf D.A. Case-control study of proximal and distal colon cancer and diet in Wisconsin. Int. J. Cancer. 49:1988;167-175.
32. Van't Veer P., Dekker J.M., Lamers J.W.J., Kok K.J., Schouten E.N., Brants H.A.M., Sturmans F., Hermus R.J.J. Consumption of fermented milk products and breast cancer: a case-control study in the Netherlands. Cancer Res. 77:1989;4020-4023.
33. Le M.G., Moulton L.H., Hill C., Kramer A. Consumption of dairy produce and alcohol in a case-control study of breast cancer. J. Natl. Cancer Inst. 139:1986;633-636.
34. Kampman E., Giovannucci E., Van't Veer P., Rimm E., Stampfer M.J., Colditz G.A., Kok F.J., Willett W.C. Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am. J. Epidemiol. 54:1994;16-29.
35. Kampman E., Goldbohm R.A., van den Brandt P.A., Van't Veer P. Fermented dairy products, calcium, and colorectal cancer in the Netherlands cohort study. Cancer Res. 5:1994;3186-3190.
36. Lidbeck A., Overvik E., Rafter J., Nord C.E., Gustafsson J.A. Effect of Lactobacillus acidophilus supplements on mutagen excretion in feces and urine in humans. Microbial Ecol. Health Dis. 73:1992;59-67.
37. Hayatsu H., Hayatsu T. Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett. 23:1993;173-179.
38. Biasco G., Paganelli G.M., Brandi G., Brillanti S., Lami F., Callegari C., Gizzi G. Effect of Lactobacillus acidophilus and Bifidobacterium bifidum on rectal cell kinetics and fecal pH. Ital. J. Gastroenterol. 78:1991;142.
39. Schiffrin E.J., Rochat F., Link-Amster H., Aeschlimann J.M., Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J. Dairy Sci. 9:1995;491-496.
40. De Simone C., Vesely R., Bianchi Salvadori B., Jirillo E. The role of probiotics in modulation of the immune system in man and in animals. Int. J. Immunother. 27:1993;23-28.
41. Kato I., Yokokura T., Mutai M. Macrophage activation by Lactobacillus casei in mice. Microbiol. Immunol. 41:1983;611-618.
42. Matsuzaki T. Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol. 16:1998;133-140.
43. Kato I., Endo K., Yokokura T. Effects of oral adminstration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int. J. Immunopharmacol. 13:1994;29-36.
44. Sekine K., Kawashima T., Hashimoto Y. Comparison of the TNF-α levels induced by human-derived Bifidobacterium longum and rat-derived Bifidobacterium animalis in mouse peritoneal cells. Bifidobacteria Microflora. 39:1994;79-89.
45. Zhang X.B., Ohta Y. Microorganisms in the gastrointestinal tract of the rat prevent absorption of the mutagen-carcinogen 3-amino-1, 4-dimethyl-5H-pyrido[4, 3-b]indole. Can. J. Microbiol. 29:1993;841-845.
46. Rowland I.R., Grasso P. Degradation of N-nitrosamines by intestinal bacteria. Appl. Microbiol. 35:1975;7-12.
47. Ayebo A.D., Angelo I.A., Shahani K.M. Effect of ingesting Lactobacillus acidophilus milk upon fecal flora and enzyme activity in humans. Milch Wissenschaft. 28:1980;730-733.
48. Biffi A., Coradini D., Larsen R., Riva L., Di Fronzo G. Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr. Cancer. 80:1997;93-99.
49. Reddy B.S. Prevention of colon cancer by pre- and probiotics: evidence from laboratory studies. Br. J. Nutr. 73:1998;S219-223.
50. Goldin B.R., Gorbach S.L. Alterations of the intestinal microflora by diet, oral antibiotics and Lactobacillus: decreased production of free amines from aromatic nitrocompounds, azo dyes and glucuronides. J. Natl. Cancer Inst. 124:1984;689-695.
51. Ling W.H., Korpela R., Mykkanen H., Salminen S., Hanninen O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J. Nutr. 64:1994;18-23.
52. Goldin B.R., Swenson L., Dwyer J., Sexton M., Gorbach S.L. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J. Natl. Cancer Inst. 52:1980;255-261.
53. Spanhaak S., Havenaar R., Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur. J. Clin. Nutr. 39:1998;899-907.
54. Goldin B.R., Gorbach S.L. The effect of milk and Lactobacillus feeding on human intestinal bacterial enzyme activity. Am. J. Clin. Nutr. 23:1984;756-761.
55. Modler G.W., Mc Kellar R.C., Yaguchi M. Bifidobacteria and bifidogenic factors. Can. Inst. Food Sci. Technol. J. 59:1990;29-41.
56. Bartram H.P., Scheppach W., Gerlach S., Ruckdeschel G., Kelber E., Kasper H. Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in healthy subjects. Am. J. Clin. Nutr. 47:1994;428-432.
57. Weisburger J.H., Wynder E.L. Etiology of colorectal cancer with emphasis on mechanism of action and prevention. De Vita V.T, Hellman S, Rosenberg S.A. Important advances in oncology. 1987;197-220 JB Lippincott, Philadelphia.
58. Bruce W.R. Recent hypotheses for the origin of colon cancer. Cancer Res. 4:1987;4237-4242.
59. Lidbeck A., Geltner-Allinger U., Orrhage K.M., Ottava L., Brismar B., Gustafsson J.A., Rafter J.J., Nord C.E. Impact of Lactobacillus acidophilus supplements on the faecal microflora and soluble faecal bile acids in colon cancer patients. Microbial Ecol. Health Dis. 38:1991;81-88.
60. Venitt S. Mutagens in human faeces and cancer of the large bowel. Rowland I.R. Role of the gut flora in toxicity and cancer. 1988;399-460 Academic Press, London.
61. Fang W.F., Strobel H.W. Activation of carcinogens and mutagens by rat colon mucosa. Cancer Res. 76:1978;2939-2944.
62. Nielsen O.H., Jorgensen S., Pedersen K., Justesen T. Microbiological evaluation of jejunal aspirates and fecal samples after oral administration of bifidobacteria and lactic acid bacteria. J. Appl. Bacteriol. 14:1994;469-474.
63. Rumney C.J., Rowland I.R., Coutts T.M., et al. Effects of risk-associated human dietary macrocomponents on processes related to carcinogenesis in human-flora-associated (HFA) rats. Carcinogenesis. 1993;79-84.